Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
CDRI compound no. 99/411 is a potent 1,2,4-trioxane antimalarial candidate drug under development at our Institute. An HPLC method for determination of CDRI 99/411 with its starting material and intermediates has been developed and validated for in process quality control and stability studies. The...
Main Authors: | Kiran Khandelwal, Shakti Deep Pachauri, Sofia Zaidi, Pankaj Dwivedi, Ashok Kumar Sharma, Chandan Singh, Anil Kumar Dwivedi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-10-01
|
Series: | Journal of Pharmaceutical Analysis |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095177913000397 |
Similar Items
-
Bio-transformation of FXR antagonist CDRI 80/574
by: Alok K. Verma, et al.
Published: (2010-06-01) -
CDRI as an Instrument to Evaluate Infants With Developmental Problems Associated With Autism
by: Nathalia Teixeira Caldas Campana, et al.
Published: (2015-04-01) -
MEASURING URBAN RESILIENCE USING CLIMATE DISASTER RESILIENCE INDEX (CDRI)
by: W. N. M. Wan Mohd Rani, et al.
Published: (2018-10-01) -
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
by: Hiroko Tsuruta, et al.
Published: (2009-01-01) -
A national survey on the effective use of the CDRI and educational TV programme in Malaysian schools
by: Mokhtar, Fattawi, et al.
Published: (2010)